AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus — Biotech startups face ‘Series A cliff’ as venture capital stays cautious— Incyte hit by CRL on extended-release JAK tablets -- See more on our front page news http://bit.ly/w28kSd #abbvie #ulcerativecolitis #lupus #startups #funding #venturecapital #seriesa #seriesb #fda #completeresponseletter #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#abbvie #ulcerativecolitis #lupus #Startups #funding #VentureCapital #seriesa #SeriesB #FdA #completeresponseletter #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma